Prudence Ive

3.7k citations

48 papers · 2.0k indexed · h-index 22

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology

Papers in ⓘ

Virology 23
- HIV Research and Treatment 23
Infectious Diseases 43
- HIV/AIDS Research and Interventions 28
- HIV/AIDS drug development and treatment 27
- Tuberculosis Research and Epidemiology 10

Co-authors: Ian Sanne (16 shared papers)Wendy Stevens (14 shared papers)Matthew P. Fox (14 shared papers)Margaret Siwale (10 shared papers)Tobias F. Rinke de Wit (10 shared papers)Raph L Hamers (10 shared papers)Kim Sigaloff (10 shared papers)Cissy Kityo (9 shared papers)
Journals: AIDS (8 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (7 papers)Clinical Infectious Diseases (6 papers)Journal of the International AIDS Society (4 papers)PLoS ONE (4 papers)
Partner nations: South Africa United States Netherlands

In The Last Decade

Prudence Ive

46 papers receiving 1.9k citations

Peers

Countries citing papers authored by Prudence Ive

Since Specialization

Citations

This map shows the geographic impact of Prudence Ive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prudence Ive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prudence Ive more than expected).

Fields of papers citing papers by Prudence Ive

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prudence Ive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prudence Ive. The network helps show where Prudence Ive may publish in the future.

Co-authors

The 25 scholars most cited alongside Prudence Ive, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Prudence Ive Line = papers co-authored together Prudence Ive links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial The Lancet ·Ian Sanne, Catherine Orrell, Matthew P. Fox, Francesca Conradie, Prudence Ive, Jennifer Zeinecker, Morna Cornell, Christie Heiberg, Charlotte Ingram, Ravindre Panchia, Mohammed Rassool, René Gonin, Wendy Stevens, Handré Truter, Marjorie Dehlinger, Charles van der Horst, James McIntyre, Robin Wood	2010	190
2	Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis The Lancet ·Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt, Christo van Niekerk, Peter R. Donald, Divan A. Burger, Robert Schall, Melvin Spigelman, Almari Conradie, Kathleen D. Eisenach, Amour Venter, Prudence Ive, Liesl Page‐Shipp, Ebrahim Variava, Klaus Reither, Nyanda Elias Ntinginya, Alexander S. Pym, Florian von Groote-Bidlingmaier, Carl M. Mendel	2015	184
3	SOLO AIDS ·Joseph Gathe, Prudence Ive, Robin Wood, Dirk Schürmann, Nicholaos Bellos, Edwin DeJesus, Andrzej Gładysz, Cindy Garris, Jane Yeo	2004	153
4	Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kim Sigaloff, Raph L Hamers, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Prudence Ive, Mariëtte E. Botes, Kishor Mandaliya, Maureen Wellington, Akin Osibogun, Wendy Stevens, Michèle van Vugt, Tobias F. Rinke de Wit	2011	151
5	Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study The Lancet Infectious Diseases ·Raph L Hamers, Rob Schuurman, Kim Sigaloff, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Kishor Mandaliya, Prudence Ive, Mariëtte E. Botes, Maureen Wellington, Akin Osibogun, Ferdinand W N M Wit, Michèle van Vugt, Wendy Stevens, Tobias F. Rinke de Wit	2011	141
6	Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies Clinical Infectious Diseases ·Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Kishor Mandaliya, Prudence Ive, M. E. Botes, Melanie Wellington, Akin Osibogun, Wendy Stevens, Tobias F. Rinke de Wit, Rob Schuurman, (unknown)	2012	137
7	Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir AIDS ·Alana T. Brennan, Denise Evans, Mhairi Maskew, Saraladevi Naicker, Prudence Ive, Ian Sanne, Thapelo Maotoe, Matthew P. Fox	2011	80
8	High Rates of Survival, Immune Reconstitution, and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa JAIDS Journal of Acquired Immune Deficiency Syndromes ·Matthew P. Fox, Prudence Ive, Lawrence Long, Mhairi Maskew, Ian Sanne	2010	71
9	Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies Clinical Infectious Diseases ·Rodolphe Thiébaut, Ana Jarné, Jean-Pierre Routy, Irini Sereti, Margaret A. Fischl, Prudence Ive, Roberto F. Speck, Gianpiero D’Offizi, Salvatore Casari, Daniel Commenges, Sharne Foulkes, Ven Natarajan, Thérèse Croughs, Jean-François Delfraissy, Giuseppe Tambussi, Yves Lévy, Michael M. Lederman	2016	61
10	Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/μl is associated with improved treatment outcomes in South Africa AIDS ·Matthew P. Fox, Ian Sanne, Francesca Conradie, Jennifer Zeinecker, Catherine Orrell, Prudence Ive, Mohammed Rassool, Marjorie Dehlinger, Charles van der Horst, James McIntyre, Robin Wood	2010	61
11	Tuberculosis Immune Reconstitution Inflammatory Syndrome in A5221 STRIDE JAIDS Journal of Acquired Immune Deficiency Syndromes ·Anne F. Luetkemeyer, Michelle A. Kendall, Mulinda Nyirenda, Xingye Wu, Prudence Ive, Constance A. Benson, Janet W. Andersen, Susan Swindells, Ian Sanne, Diane V. Havlir, Johnstone Kumwenda	2013	58
12	Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa The Journal of Infectious Diseases ·Kim Sigaloff, Raph L Hamers, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Prudence Ive, M. E. Botes, Kishor Mandaliya, Melanie Wellington, Akin Osibogun, Wendy Stevens, Michèle van Vugt, Tobias F. Rinke de Wit, (unknown)	2012	55
13	HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes JAIDS Journal of Acquired Immune Deficiency Syndromes ·Raph L Hamers, Hans L. Zaaijer, Carole L. Wallis, Margaret Siwale, Prudence Ive, Mariëtte E. Botes, Kim Sigaloff, Andy I. M. Hoepelman, Wendy Stevens, Tobias F. Rinke de Wit	2013	55
14	Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study Clinical Infectious Diseases ·Anne F. Luetkemeyer, Susan L. Rosenkranz, Darlene Lu, Florence Marzan, Prudence Ive, Evelyn Hogg, Susan Swindells, Constance A. Benson, Beatriz Grinsztejn, Ian Sanne, Diane V. Havlir, Francesca Aweeka	2013	51
15	Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa AIDS ·Stefanie Kroeze, Pascale Ondoa, Cissy Kityo, Margaret Siwale, Sulaimon Akanmu, Maureen Wellington, Marleen de Jager, Prudence Ive, Kishor Mandaliya, Wendy Stevens, T. Sonia Boender, Marieke E. de Pundert, Kim Sigaloff, Peter Reiss, Ferdinand W.N.M. Wit, Tobias F. Rinke de Wit, Raph L Hamers	2018	50
16	Intensive adherence counselling for HIV‐infected individuals failing second‐line antiretroviral therapy in Johannesburg, South Africa Tropical Medicine & International Health ·Matthew P. Fox, Rebecca Berhanu, Kim Steegen, Cindy Firnhaber, Prudence Ive, David Spencer, Sello Mashamaite, Sadiyya Sheik, Ingrid Jonker, Pauline Howell, Lawrence Long, Denise Evans	2016	48
17	Natural Killer Cell Activation Distinguishes Mycobacterium tuberculosis–Mediated Immune Reconstitution Syndrome From Chronic HIV and HIV/MTB Coinfection JAIDS Journal of Acquired Immune Deficiency Syndromes ·Francesca Conradie, Andrea S. Foulkes, Prudence Ive, Xiangfan Yin, Katerina Roussos, Deborah K. Glencross, Denise Lawrie, Wendy Stevens, Luis J. Montaner, Ian Sanne, Livio Azzoni	2011	42
18	Effect of pulmonary tuberculosis on mortality in patients receiving HAART AIDS ·Daniel Westreich, Patrick MacPhail, Annelies Van Rie, Babatyi Malope‐Kgokong, Prudence Ive, Dennis Rubel, Ronan Boulmé, Joseph J. Eron, Ian Sanne	2009	35
19	Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1 AIDS ·David A. Cooper, Jayvant Heera, Prudence Ive, Mariëtte E. Botes, Edwin DeJesus, Robert Burnside, Nathan Clumeck, Sharon Walmsley, Adriano Lazzarin, Geoffrey Mukwaya, Michael S. Saag, Elna van der Ryst	2013	30
20	Identification of a 251 Gene Expression Signature That Can Accurately Detect M. tuberculosis in Patients with and without HIV Co-Infection PLoS ONE ·Noor Dawany, Louise C. Showe, Andrew V. Kossenkov, Celia Chang, Prudence Ive, Francesca Conradie, Wendy Stevens, Ian Sanne, Livio Azzoni, Luis J. Montaner	2014	30

About Prudence Ive

Prudence Ive is a scholar working on Virology, Infectious Diseases, Epidemiology, Hepatology and Emergency Medicine, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (28 papers), HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (23 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers), Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (5 papers), HIV/AIDS Impact and Responses (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Virology (950 citations), Infectious Diseases (1.7k citations), Epidemiology (702 citations), Emergency Medicine (176 citations) and Hepatology (108 citations). Prudence Ive has collaborated with scholars based in South Africa, United States and Netherlands. Frequent co-authors include Ian Sanne, Wendy Stevens, Matthew P. Fox, Margaret Siwale, Tobias F. Rinke de Wit, Raph L Hamers, Kim Sigaloff, Cissy Kityo, Carole L. Wallis and Kishor Mandaliya. Their work appears in journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical Infectious Diseases, Journal of the International AIDS Society and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact